Tailored Lipoprotein‐Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor‐Stimulated Macropinocytosis-Reference-Cited by-全球学者库

Tailored Lipoprotein‐Like miRNA Delivery Nanostructure Suppresses Glioma Stemness and Drug Resistance through Receptor‐Stimulated Macropinocytosis

Published:2020-01-20 Issue:5 Volume:7 Page:1903290
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Jiang Gan¹^ORCID,Chen Huan¹²,Huang Jialin¹³,Song Qingxiang¹,Chen Yaoxing¹,Gu Xiao¹,Jiang Zhenhuan¹,Huang Yukun⁴,Lin Yingying³,Feng Junfeng³,Jiang Jiyao³,Bao Yinghui³,Zheng Gang⁵,Chen Jun⁴,Chen Hongzhuan¹²,Gao Xiaoling¹^ORCID

Affiliation:

1. Department of Pharmacology and Chemical BiologyShanghai Universities Collaborative Innovation Center for Translational MedicineShanghai Jiao Tong University School of Medicine 280 South Chongqing Road Shanghai 200025 China

2. Institute of Interdisciplinary Integrative Biomedical ResearchShuguang HospitalShanghai University of Traditional Chinese Medicine 1200 Cailun Road Shanghai 201210 China

3. Department of Neurological SurgeryRenji HospitalShanghai Jiao Tong University School of Medicine 1630 Dongfang Road Shanghai 200127 China

4. Key Laboratory of Smart Drug DeliveryMinistry of EducationSchool of PharmacyFudan University 826 Zhangheng Road Shanghai 201203 China

5. Department of Medical Biophysics and Ontario Cancer InstituteUniversity of Toronto Ontario M5G 1L7 Canada

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Education Commission

Shanghai Education Development Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.201903290

Reference51 articles.

1. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting

4. Targeting glioma stem cells through combined BMI1 and EZH2 inhibition

5. Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature‐on‐a‐Chip System Correlates with Tumor Heterogeneity and Subtypes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered bacterial extracellular vesicles for central nervous system diseases;Journal of Controlled Release;2023-12

2. A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy;Biomaterials;2023-11

3. Nanotechnologies meeting natural sources: Engineered lipoproteins for precise brain disease theranostics;Asian Journal of Pharmaceutical Sciences;2023-09

4. Programmable Peptides Activated Macropinocytosis for Direct Cytosolic Delivery;Advanced Healthcare Materials;2023-07-21

5. Targeted drug delivery system inspired by macropinocytosis;Journal of Controlled Release;2023-07